JAGXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Jaguar Health, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 19, 2026
$2.82−0.71 (-20.00%)
Close on Oct 19, 2026
- Market cap
- $2.28M
- P/E (TTM)
- –
- Dividend yield
- –
Jaguar Health statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Pharmaceutical Preparations companies for comparison
Valuation
| Measure | Jaguar Health | Industry median |
|---|---|---|
| Market Cap | $14.57M | $164.85M |
| Enterprise Value | $10.82M | $87.06M |
| PS Ratio | 0.52 | 3.60 |
Enterprise value
| Measure | Jaguar Health | Industry median |
|---|---|---|
| EV / Sales | 0.39 | 2.43 |
Income (trailing twelve months)
| Measure | Jaguar Health | Industry median |
|---|---|---|
| Revenue | $27.82M | $57.94M |
| Gross Profit | $22.89M | $90.47M |
| Operating Income | -$25.90M | -$21.44M |
| Pretax Income | -$36.92M | -$14.45M |
| EBITDA | -$23.99M | -$16.91M |
Margins
| Measure | Jaguar Health | Industry median |
|---|---|---|
| Gross Margin | 82.3% | 52.3% |
| Operating Margin | -93.1% | -44.5% |
| Pretax Margin | -132.7% | -13.0% |
| EBITDA Margin | -86.3% | -31.3% |
Returns
| Measure | Jaguar Health | Industry median |
|---|---|---|
| Return on Capital Employed (ROCE) | -293.8% | -37.8% |
Growth
| Measure | Jaguar Health | Industry median |
|---|---|---|
| Revenue Growth (YoY) | 135.5% | 6.01% |
| Revenue Growth (3Y CAGR) | -1.26% | 2.25% |
| Revenue Growth (5Y CAGR) | 4.17% | 6.42% |
Balance sheet
| Measure | Jaguar Health | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $3.79M | $62.42M |
| Total Debt | $1.73M | $120.13M |
| Net Cash (Debt) | $2.06M | $15.68M |
| Net Cash Per Share | $0.40 | $0.66 |
| Working Capital | -$7.85M | $75.77M |
Financial position
| Measure | Jaguar Health | Industry median |
|---|---|---|
| Current Ratio | 0.69 | 3.30 |
| Quick Ratio | 0.15 | 2.39 |
| Interest Coverage | -25.95 | -7.12 |
Cash flow (trailing twelve months)
| Measure | Jaguar Health | Industry median |
|---|---|---|
| Operating Cash Flow | -$6.69M | -$12.35M |
Efficiency
| Measure | Jaguar Health | Industry median |
|---|---|---|
| Asset Turnover | 0.67 | 0.38 |
| Inventory Turnover | 0.55 | 2.67 |
| Revenue Per Employee | $591.81K | $398.96K |
| Employee Count | 47 | 74 |
Shares
| Measure | Jaguar Health | Industry median |
|---|---|---|
| Shares Outstanding | 5,168,300 | 58,179,650 |
| Float | 4,282,510 | 49,173,100 |
| Shares Held by Insiders | 17.1% | 11.6% |
Scores
| Measure | Jaguar Health | Industry median |
|---|---|---|
| Altman Z-Score | -18.19 | -0.24 |
| Piotroski F-Score | 2 | 4 |
| Beneish M-Score | -6.28 | -2.62 |
Calculated by StockData from Jaguar Health's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.